AkboğaMKGokaslanSBalciKGYaylaÇDemirtasK. Endocan to predict cardiovascular events: a promising biomarker or a coincidental finding?Angiology. 2017;68(1):84.
2.
KundiHBalunACicekciogluH. Admission endocan level may be a useful predictor for in-hospital mortality and coronary severity index in patients with ST-segment elevation myocardial infarction. Angiology. 2017;68(1):46–51.
3.
KundiHKiziltuncECetinM. Association of monocyte/HDL-C ratio with SYNTAX scores in patients with stable coronary artery disease. Herz. 2016;41(6):523–529.
4.
AkboğaMKCanpolatUYaylaÇ. Association of platelet to lymphocyte ratio with inflammation and severity of coronary atherosclerosis in patients with stable coronary artery disease. Angiology. 2016;67(1):89–95.
5.
SönmezOErtaşGBacaksızA. Relation of neutrophil-to-lymphocyte ratio with the presence and complexity of coronary artery disease: an observational study. Anatol J Cardiol. 2013;13(7):662–667.
6.
KurtulAYarliogluesMCelikIEAssociation of lymphocyte-to-monocyte ratio with the no-reflow phenomenon in patients who underwent a primary percutaneous coronary intervention for ST-elevation myocardial infarction. Coron Artery Dis. 2015;26(8):706–712.
7.
AkboğaMKBalciKGMadenO. Usefulness of monocyte to HDL-cholesterol ratio to predict high SYNTAX score in patients with stable coronary artery disease. Biomark Med. 2016;10(4):375–383.
8.
BaltaSCelikTMikhailidisDP. The relation between atherosclerosis and the neutrophil-lymphocyte ratio. Clin Appl Thromb Hemost. 2016;22(5):405–411.
9.
KoseMEmetSAkpinarTS. Serum endocan level and the severity of coronary artery disease: a pilot study. Angiology. 2015;66(8):727–731.
10.
BaltaSMikhailidisDPDemirkolSOzturkCCelikTIyisoyA. Endocan: a novel inflammatory indicator in cardiovascular disease?Atherosclerosis. 2015;243(1):339–343.
11.
ÜnalSAçarBErtemAGŞenF. Endocan in hypertension and cardiovascular diseases. Angiology. 2017;68(1):85.
